Visual impairment (VI), defined as low vision or blindness, affects approximately 441.1 million individuals, disproportionately affecting individuals 50 years and older.
1 With the rapidly aging populations,
2 the prevalence of VI is expected to increase 3-fold by 2050.
1 VI imposes a substantial health burden in terms of quality-adjusted life-years or years lived with disability that is comparable to major chronic diseases, such as diabetes, dyslipidemia, cardiovascular diseases (CVD), and obesity.
3,4 Likewise, deficits in cognitive function are also a major cause of morbidity.
4 Previous studies
5-7 have found a close association between VI and decline in cognitive function.